Search - Institut Pasteur Access content directly

Filter your results

9 Results
authFullName_s : Francisco Pozo
Image document

Effectiveness of Influenza Vaccine against Influenza A in Europe in Seasons of Different A(H1N1)Pdm09 and the Same A(H3N2) Vaccine Components (2016\textendash 17 and 2017\textendash 18)

Esther Kissling , Francisco Pozo , Silke Buda , Ana-Maria Vilcu , Caterina Rizzo , et al.
Vaccine: X, 2019, 3, pp.100042. ⟨10.1016/j.jvacx.2019.100042⟩
Journal articles hal-03846533v1
Image document

2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children

Esther Kissling , Marta Valenciano , Francisco Pozo , Ana-Maria Vilcu , Annicka Reuss , et al.
Influenza and Other Respiratory Viruses, 2018, 12 (4), pp.423-437. ⟨10.1111/irv.12520⟩
Journal articles hal-02102565v1

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

Esther Kissling , Mariëtte Hooiveld , Iván Martínez-Baz , Clara Mazagatos , Naoma William , et al.
Eurosurveillance, 2022, 27 (21), ⟨10.2807/1560-7917.ES.2022.27.21.2101104⟩
Journal articles hal-04000488v1
Image document

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

Gianfranco Spiteri , James Fielding , Michaela Diercke , Christine Campese , Vincent Enouf , et al.
Eurosurveillance, 2020, 25 (9), ⟨10.2807/1560-7917.ES.2020.25.9.2000178⟩
Journal articles pasteur-04098523v1
Image document

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Marc Rondy , Esther Kissling , Hanne-Dorthe Emborg , Alin Gherasim , Richard Pebody , et al.
Eurosurveillance, 2018, 23 (9), ⟨10.2807/1560-7917.ES.2018.23.9.18-00086⟩
Journal articles hal-01976967v1

Low 2018/19 Vaccine Effectiveness against Influenza A(H3N2) among 15\textendash 64-Year-Olds in Europe: Exploration by Birth Cohort

Esther Kissling , Francisco Pozo , Silke Buda , Ana-Maria Vilcu , Alin Gherasim , et al.
Eurosurveillance, 2019, 24 (48), ⟨10.2807/1560-7917.ES.2019.24.48.1900604⟩
Journal articles hal-03846534v1

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Esther Kissling , Angela Rose , Hanne-Dorthe Emborg , Alin Gherasim , Richard Pebody , et al.
Eurosurveillance, 2019, 24 (8), pp.21. ⟨10.2807/1560-7917.ES.2019.24.1900121⟩
Journal articles hal-02355359v1
Image document

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study

Esther Kissling , Francisco Pozo , Iván Martínez-Baz , Silke Buda , Ana‐maria Vilcu , et al.
Influenza and Other Respiratory Viruses, 2023, 17 (1), pp.e13069. ⟨10.1111/irv.13069⟩
Journal articles pasteur-04097905v1
Image document

Vaccine Effectiveness against Symptomatic SARS-CoV-2 Infection in Adults Aged 65 Years and Older in Primary Care: I-MOVE-COVID-19 Project, Europe, December 2020 to May 2021

Esther Kissling , Mariëtte Hooiveld , Virginia Sandonis Martin , Iván Martinez-Baz , Naoma William , et al.
Eurosurveillance, 2021, 26 (29), ⟨10.2807/1560-7917.ES.2021.26.29.2100670⟩
Journal articles hal-03846535v1